Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Greg Zipfel"'
Autor:
Constantinos G. Hadjipanayis, Analiz Rodriguez, Jian Campian, Melanie Hayden Gephart, Daniel A. Orringer, Jennifer S. Yu, Ali Jalali, James Battiste, Gavin P. Dunn, Akash J. Patel, Peter E. Fecci, Dimitris G. Placantonakis, Eric C. Leuthardt, Albert H. Kim, Sunit Das, Kimberly B Hoang, Mario L. Suvà, Ralph G. Dacey, Milan G. Chheda, Greg Zipfel, Nduka Amankulor, Isaac Yang, Edjah K. Nduom
Publikováno v:
Neurosurgery. 89:129-132
Patients with glioblastoma (GBM) need bold new approaches to their treatment, yet progress has been hindered by a relative inability to dynamically track treatment response, mechanisms of resistance, evolution of targetable mutations, and changes in
Autor:
Ridhima Guniganti, Santiago Ortega-Gutierrez, G. Lanzino, Colin P. Derdeyn, Edgar A. Samaniego, Sepideh Amin-Hanjani, Greg Zipfel, Minako Hayakawa, Jorge A Roa, Ali Alaraj, Diederik Bulters, David Hasan
Publikováno v:
Electronic Poster Abstracts.
Background Current evidence suggests that intracranial dural arteriovenous fistulas (dAVFs) lacking cortical venous drainage (CVD) have a benign clinical course. However, there is no large study evaluating the safety/efficacy of current treatments an
Autor:
DeWitte T. Cross, C Chou, Ralph G. Dacey, R Rimer, Matthew J. Austin, Adam N. Wallace, Akash P. Kansagra, Mudassar Kamran, Joshua W. Osbun, Greg Zipfel, Christopher J. Moran
Publikováno v:
Electronic Poster Abstracts.
Background Endovascular treatment of lesions associated with the cerebellar arteries is ideally performed with preservation of cerebellar artery flow, but cerebellar artery sacrifice may sometimes be necessary. Clinical outcomes and complication rate
Autor:
Greg Zipfel, Sandra Magnoni, Nino Stocchetti, Thomas J. Esparza, David M. Holtzman, David L. Brody, Valeria Conte, Marco Carbonara, Giorgio Carrabba
Publikováno v:
ResearcherID
Axonal injury is believed to be a major determinant of adverse outcomes following traumatic brain injury. However, it has been difficult to assess acutely the severity of axonal injury in human traumatic brain injury patients. We hypothesized that mi
Autor:
Franz J. Wippold, Charles F. Garvin, James G. Smirniotopoulos, Sepideh Amin-Hanjani, Daniel F. Broderick, Laszlo L. Mechtler, Paul J. Tobben, David Seidenwurm, Douglas C. Brown, Edgardo J. Angtuaco, Alan D. Waxman, Robert L. DeLaPaz, Brian L. Hoh, Charles T. McConnell, Greg Zipfel, Patricia C. Davis, Rebecca S. Cornelius, Jeff L. Creasy
Publikováno v:
Journal of the American College of Radiology. 8:532-538
Stroke is the sudden onset of focal neurologic symptoms due to ischemia or hemorrhage in the brain. Current FDA-approved clinical treatment of acute ischemic stroke involves the use of the intravenous thrombolytic agent recombinant tissue plasminogen
Autor:
Richard A. Chole, Ralph G. Dacey, Michael R. Chicoine, Greg Zipfel, John Spencer Evans, Keith M. Rich, Albert H. Kim, Bruce H. Haughey, Ravindra Uppaluri, Peter T Sylvester
Publikováno v:
Journal of Neurological Surgery Part B: Skull Base. 76
Autor:
Colin Derdeyn, James Sagar, John Lee, Venkatesh Aiyagari, Patricia Davis, Cristina Ivan, Shyam Prabhakaran, Lina Shinawi, Nancy Hantler, Allyson Zazulia, Robert Grubb, Greg Zipfel
Publikováno v:
Stroke. 43
Background: The natural history of moyamoya phenomenon is not well defined. Hemodynamic factors are likely involved in the risk of future stroke in these patients. The purpose of this study was to determine if severe hemodynamic impairment predicted
Autor:
John Spencer Evans, Greg Zipfel, Ralph G. Dacey, Michael R. Chicoine, Keith M. Rich, Franz J. Wippold
Publikováno v:
Skull Base. 21
Autor:
Thomas J. Esparza, Christine MacDonald, Greg Zipfel, Sandra Magnoni, David M. Holtzman, David L. Brody, Kate E. Schwetye, Michael L. Spinner, Nino Stocchetti
Publikováno v:
Alzheimer's & Dementia. 5
Autor:
Michael L. Spinner, Nino Stocchetti, David M. Holtzman, Greg Zipfel, David L. Brody, Thomas J. Esparza, Kate E. Schwetye, Sandra Magnoni
Publikováno v:
2009 3rd International Conference on Bioinformatics and Biomedical Engineering.
The amyloid-β peptide (Aβ) plays a central pathophysiological role in Alzheimer’s disease, but little is known about the concentration and dynamics of this secreted peptide in the extracellular space of the human brain. We used intracerebral micr